Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 975,543 | 1,003,578 | 964,095 | 901,601 | 915,527 |
| Cost of Goods | 379,505 | 384,419 | 371,025 | 375,434 | 367,545 |
| Gross Profit | 596,038 | 619,159 | 593,070 | 526,167 | 547,982 |
| Operating Expenses | 292,651 | 355,777 | 294,137 | 281,299 | 273,244 |
| Operating Income | 303,892 | 263,801 | 298,958 | 245,302 | 275,283 |
| Interest Expense | 7,697 | 8,099 | 7,911 | 9,265 | 8,647 |
| Other Income | 2,714 | 3,354 | 4,432 | 3,631 | 1,255 |
| Pre-tax Income | 298,909 | 259,056 | 295,479 | 239,668 | 267,891 |
| Income Tax | 66,068 | 55,758 | 59,900 | 45,147 | 55,660 |
| Net Income Continuous | 232,841 | 203,298 | 235,579 | 194,521 | 212,231 |
| Net Income | $232,841 | $203,298 | $235,579 | $194,521 | $212,231 |
| EPS Basic Total Ops | 2.83 | 2.46 | 2.84 | 2.34 | 2.55 |
| EPS Basic Continuous Ops | 2.83 | 2.46 | 2.84 | 2.34 | 2.55 |
| EPS Diluted Total Ops | 2.80 | 2.44 | 2.81 | 2.31 | 2.53 |
| EPS Diluted Continuous Ops | 2.80 | 2.44 | 2.81 | 2.32 | 2.53 |
| EPS Diluted Before Non-Recurring Items | 2.80 | 2.44 | 2.81 | N/A | N/A |
| EBITDA(a) | $338,025 | $295,994 | $328,862 | $275,039 | $304,268 |